Cargando…
Development of an Inactivated H7N9 Subtype Avian Influenza Serological DIVA Vaccine Using the Chimeric HA Epitope Approach
H7N9 avian influenza virus (AIV) is an emerging zoonotic pathogen, and it is necessary to develop a differentiating infected from vaccinated animals (DIVA) vaccine for the purpose of eradication. H7N9 subtype AIV hemagglutinin subunit 2 glycoprotein (HA2) peptide chips and antisera of different AIV...
Autores principales: | Sun, Zhihao, Wang, Qiuxia, Li, Gang, Li, Jingzhi, Chen, Sujuan, Qin, Tao, Ma, Hongwei, Peng, Daxin, Liu, Xiufan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557892/ https://www.ncbi.nlm.nih.gov/pubmed/34585985 http://dx.doi.org/10.1128/Spectrum.00687-21 |
Ejemplares similares
-
Identification of a universal antigen epitope of influenza A virus using peptide microarray
por: Wang, Qiuxia, et al.
Publicado: (2021) -
Generation of an avian influenza DIVA vaccine with a H3-peptide replacement located at HA2 against both highly and low pathogenic H7N9 virus
por: Li, Gang, et al.
Publicado: (2022) -
Development of a multiplex probe combination-based one-step real-time reverse transcription-PCR for NA subtype typing of avian influenza virus
por: Sun, Zhihao, et al.
Publicado: (2017) -
Truncation or Deglycosylation of the Neuraminidase Stalk Enhances the Pathogenicity of the H5N1 Subtype Avian Influenza Virus in Mallard Ducks
por: Chen, Sujuan, et al.
Publicado: (2020) -
The synergistic effect of residues 32T and 550L in the PA protein of H5 subtype avian influenza virus contributes to viral pathogenicity in mice
por: Yang, Hui, et al.
Publicado: (2023)